In both studies, increased tumour PC infiltrate, defined by morphological assessment under the microscope or CD138+ immunohistochemical positivity, was independently associated with poorer cancer-specific survival (p < 0.001) among patients with primary operable invasive ductal breast cancer [39,40]. This evidence concerns the gene SDC1 and cancer.